<DOC>
	<DOCNO>NCT01043250</DOCNO>
	<brief_summary>In study , go investigate quantitative qualitative nature appetite eating-behavior change induce atypical antipsychotic , i.e. , risperidone , olanzapine aripiprazole , schizophrenia patient .</brief_summary>
	<brief_title>Effects Atypical Antipsychotics Appetite Eating Behavior Schizophrenia Patients</brief_title>
	<detailed_description>This observational study . 2 Self-report questionnaire assess change appetite eat behavior medication apply patient receive one three atypical antipsychotic . We go compare change appetite eat behavior medication three atypical antipsychotic investigate association change appetite eat behavior change weight medication .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Patients meet DSMIV criterion schizophrenia , schizophreniform disorder , schizoaffective disorder 2 . Male female patient age 19~59 3 . Patients receive monotherapy one three AAPs , i.e. , olanzapine , risperidone , aripiprazole two less 24 month 4 . Patients least oneweek antipsychoticsfree period start antipsychotic 5 . Clinically stable able complete questionnaire 6 . Patients sufficiently understand objective study sign inform consent form 1 . Patients medical illness take medicine affect appetite body weight 2 . Patients severe unstable medical , neurological systemic illness 3 . Patients comorbid psychiatric disorder include substance use disorder eat disorder . 4 . Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>atypical antipsychotic</keyword>
	<keyword>appetite</keyword>
	<keyword>eat behavior</keyword>
</DOC>